| Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells | |
| Wu, Lili; Wang, Ziyuan; Sun, Xiaoting; Feng, Yuanyuan; Liu, Xuan; Zhou, Lihong; Sui, Hua; Ji, Qing; Qiukai, E.; Chen, Jia | |
| 刊名 | ANTI-CANCER DRUGS
 |
| 2017 | |
| 卷号 | 28期号:3 |
| 关键词 | colorectal cancer dihydromyricetin multidrug resistance protein 2 nuclear factor-erythroid 2 p45 related factor 2 |
| ISSN号 | 0959-4973 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3642202 |
| 专题 | 上海中医药大学 |
| 推荐引用方式 GB/T 7714 | Wu, Lili,Wang, Ziyuan,Sun, Xiaoting,et al. Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells[J]. ANTI-CANCER DRUGS,2017,28(3). |
| APA | Wu, Lili.,Wang, Ziyuan.,Sun, Xiaoting.,Feng, Yuanyuan.,Liu, Xuan.,...&Li, Qi.(2017).Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells.ANTI-CANCER DRUGS,28(3). |
| MLA | Wu, Lili,et al."Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells".ANTI-CANCER DRUGS 28.3(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论